131 related articles for article (PubMed ID: 36608441)
1. Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
Int Immunopharmacol; 2023 Feb; 115():109656. PubMed ID: 36608441
[TBL] [Abstract][Full Text] [Related]
2. Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
Ji B; Liu J; Yin Y; Xu H; Shen Q; Yu J
Cell Death Dis; 2023 Sep; 14(9):601. PubMed ID: 37689694
[TBL] [Abstract][Full Text] [Related]
3. Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.
Ma Y; Liu J; Liu H; Han X; Sun L; Xu H
Int Immunopharmacol; 2022 Apr; 105():108549. PubMed ID: 35086056
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
5. Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.
Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
Appl Biochem Biotechnol; 2023 Dec; 195(12):7379-7396. PubMed ID: 37000351
[TBL] [Abstract][Full Text] [Related]
6. The influence of angiopoietin-like protein 3 on macrophages polarization and its effect on the podocyte EMT in diabetic nephropathy.
Ma Y; Chen Y; Xu H; Du N
Front Immunol; 2023; 14():1228399. PubMed ID: 37638046
[TBL] [Abstract][Full Text] [Related]
7. A novel role of angiopoietin-like-3 associated with podocyte injury.
Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H
Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887
[TBL] [Abstract][Full Text] [Related]
8. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
[TBL] [Abstract][Full Text] [Related]
9. Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.
Han X; Dai R; Zhai Y; Shen Q; Sun L; Liu H; Xu H
Biochem Biophys Res Commun; 2019 Aug; 516(3):812-818. PubMed ID: 31256934
[TBL] [Abstract][Full Text] [Related]
10. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
11. Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy.
Zhang F; Liu J; Yu J; Sun W; Wang Y; Fan T; Sun Y; Han X
Evid Based Complement Alternat Med; 2022; 2022():9921679. PubMed ID: 38149181
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.
Ma Y; Xie D; Liu J; Han X; Xu H; Chen Y
Int Immunopharmacol; 2023 Feb; 115():109715. PubMed ID: 37724955
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
14. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
15. A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.
Ma Q; Hu X; Liu F; Cao Z; Han L; Zhou K; Bai Y; Zhang Y; Nan Y; Lv Q; Rao J; Wu T; Yang X; He H; Ju D; Xu H
Front Immunol; 2022; 13():1011442. PubMed ID: 36544775
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
18. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression.
Li G; Lu D; Wang J; Yue S; Tan M; Liu M; Gao X
Lipids Health Dis; 2022 Sep; 21(1):90. PubMed ID: 36123608
[TBL] [Abstract][Full Text] [Related]
20. Rhodojaponin II attenuates kidney injury by regulating TGF-β1/Smad pathway in mice with adriamycin nephropathy.
Qiu Y; Zhou J; Zhang H; Zhou H; Tang H; Lei C; Ye C; You C; Chen Y; Wang Y; Xiong J; Su H; Yao G; Zhang C
J Ethnopharmacol; 2019 Oct; 243():112078. PubMed ID: 31301369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
